Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $841.5800 (-0.01%) ($841.5800 - $841.5800) on Thu. Dec. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.14% (three month average) | RSI | 65 | Latest Price | $841.5800(-0.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.8% a day on average for past five trading days. | Weekly Trend | REGN advances 1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) SDY(75%) IVE(72%) IBB(66%) XLF(66%) XLV(65%) | Factors Impacting REGN price | REGN will decline at least -0.57% in a week (0% probabilities). VXX(-93%) VIXM(-60%) UNG(-23%) TBT(-19%) BNDX(-14%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.57% (StdDev 1.14%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $847.6(-0.71%) | 10 Day Moving Average | $854.01(-1.46%) | 20 Day Moving Average | $836.87(0.56%) | To recent high | -4% | To recent low | 8.6% | Market Cap | $89.232b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |